Erbium, Chromium: Yttrium, Scandium, Gallium, Garnet (Er,Cr:YSGG) Laser in Root Canal Disinfection
Launched by UNIVERSITY OF PENNSYLVANIA · Jul 17, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a special laser called Erbium, Chromium: Yttrium, Scandium, Gallium, Garnet (Er,Cr:YSGG) to help disinfect root canals during dental treatments. The goal is to see how effective this laser is at cleaning out harmful bacteria in the tooth compared to other common treatments. This study is currently looking for participants who are 18 years and older and are in good health, have a specific type of tooth infection, and have not had previous treatment on the affected tooth.
If you decide to participate, you will receive the laser treatment during a routine root canal procedure. The study will require you to agree to follow certain guidelines and be available for the duration of the research. It's important to note that pregnant individuals and those with certain dental issues or ongoing health concerns may not be eligible. Overall, this trial aims to improve how dentists treat root canal infections, potentially leading to better outcomes for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Provision of signed and dated informed consent form.
- • Stated willingness to comply with all study procedures and availability for the duration of the study.
- • Male or female (Gender is not an inclusion or exclusion criteria), aged 18 years old or above.
- • In good general health as evidenced by medical history or non-contributory medical history (Patient can be seen for regular dental appointment in Penn Dental Medicine; American Society of Anesthesiologists (ASA) classes I and II).
- • Radiographic presence of periapical radiolucency.
- • Negative response to thermal sensitivity testing (difluorochloromethane at -50 °C, Endo-Ice, Coltène/Whaledent Inc., Cuyahoga Falls, Ohio) or electric pulp testing.
- • Enough tooth structure for adequate isolation with rubber dam.
- • No history of previous endodontic treatment on the tooth.
- • Teeth with single canal, 1 distal canal of lower molar, 1 palatal canal of upper molar.
- Exclusion Criteria:
- • Patients who report they are pregnant.
- • Teeth affected by dental trauma.
- • Periodontal changes (pockets 3 mm, mobility I or gingival edema).
- • Radiographic presence of resorptive processes.
- • Per the investigator's discretion, unable or unlikely to comply with study procedure.
- • Presence of any condition which, in the opinion of the investigator, makes participation in the study not in the individual's best interest.
About University Of Pennsylvania
The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Bekir Karabucak, DMD, MS.
Principal Investigator
Chair and Professor of Endodontics. Postdoctoral Endodontics Program, Director.
Flavia Teles, DDS,MS,DMSc
Principal Investigator
Associate Professor, Department of Basic & Translational Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported